| 0 |
GRIP STRENGTH |
118 |
0.5153 |
| 1 |
TESTICULAR GERM CELL CANCER METASTATIC |
13 |
0.4815 |
| 2 |
COMPUTERISED TOMOGRAM THORAX |
23 |
0.3833 |
| 3 |
SWOLLEN JOINT COUNT |
77 |
0.3080 |
| 4 |
INJECTION SITE VASCULITIS |
12 |
0.2105 |
| 5 |
INFUSION SITE STREAKING |
15 |
0.1724 |
| 6 |
PROCALCITONIN DECREASED |
12 |
0.1714 |
| 7 |
ACQUIRED PORPHYRIA |
11 |
0.1549 |
| 8 |
LUPUS VULGARIS |
170 |
0.1349 |
| 9 |
PULMONARY SEPTAL THICKENING |
12 |
0.1348 |
| 10 |
PORPHYRIA ACUTE |
165 |
0.1150 |
| 11 |
INJECTION SITE PHLEBITIS |
26 |
0.1111 |
| 12 |
X-RAY ABNORMAL |
192 |
0.1073 |
| 13 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
208 |
0.1038 |
| 14 |
C-REACTIVE PROTEIN |
93 |
0.1003 |
| 15 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
67 |
0.1003 |
| 16 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
193 |
0.0931 |
| 17 |
NAIL BED INFLAMMATION |
29 |
0.0909 |
| 18 |
RETINITIS |
156 |
0.0902 |
| 19 |
DISLOCATION OF VERTEBRA |
196 |
0.0859 |
| 20 |
FACET JOINT SYNDROME |
257 |
0.0789 |
| 21 |
DUODENAL ULCER PERFORATION |
569 |
0.0764 |
| 22 |
TONSILLAR HAEMORRHAGE |
11 |
0.0753 |
| 23 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
483 |
0.0743 |
| 24 |
SWOLLEN JOINT COUNT INCREASED |
231 |
0.0724 |
| 25 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
503 |
0.0701 |
| 26 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
43 |
0.0626 |
| 27 |
RHEUMATIC FEVER |
275 |
0.0616 |
| 28 |
IMMUNOTOXICITY |
7 |
0.0614 |
| 29 |
EOSINOPHIL PERCENTAGE DECREASED |
12 |
0.0603 |
| 30 |
MUSCLE INJURY |
495 |
0.0597 |
| 31 |
COLONY STIMULATING FACTOR THERAPY |
12 |
0.0580 |
| 32 |
SEMINOMA |
13 |
0.0546 |
| 33 |
FOLLICULITIS |
572 |
0.0545 |
| 34 |
HELICOBACTER INFECTION |
559 |
0.0543 |
| 35 |
RHEUMATOID FACTOR POSITIVE |
295 |
0.0510 |
| 36 |
BONE EROSION |
167 |
0.0472 |
| 37 |
NASAL MUCOSAL DISORDER |
27 |
0.0463 |
| 38 |
ANTIPHOSPHOLIPID ANTIBODIES |
9 |
0.0462 |
| 39 |
ANTINUCLEAR ANTIBODY |
7 |
0.0443 |
| 40 |
PERIPHERAL VENOUS DISEASE |
178 |
0.0435 |
| 41 |
HAND DEFORMITY |
567 |
0.0432 |
| 42 |
BLOOD CREATINE DECREASED |
13 |
0.0430 |
| 43 |
C-REACTIVE PROTEIN ABNORMAL |
276 |
0.0430 |
| 44 |
PEMPHIGUS |
474 |
0.0379 |
| 45 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
21 |
0.0374 |
| 46 |
BREAST CANCER STAGE III |
221 |
0.0341 |
| 47 |
DRUG TOLERANCE DECREASED |
95 |
0.0338 |
| 48 |
APLASIA |
59 |
0.0301 |
| 49 |
ENTEROBACTER BACTERAEMIA |
9 |
0.0297 |
| 50 |
INTERCEPTED DRUG ADMINISTRATION ERROR |
13 |
0.0296 |
| 51 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
110 |
0.0293 |
| 52 |
PERICARDITIS |
492 |
0.0293 |
| 53 |
CULTURE STOOL POSITIVE |
8 |
0.0292 |
| 54 |
SYNOVITIS |
522 |
0.0289 |
| 55 |
STREPTOCOCCAL SEPSIS |
34 |
0.0287 |
| 56 |
LIP DRY |
253 |
0.0278 |
| 57 |
DENTAL FISTULA |
11 |
0.0264 |
| 58 |
GLOSSODYNIA |
581 |
0.0259 |
| 59 |
FEBRILE BONE MARROW APLASIA |
105 |
0.0247 |
| 60 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
11 |
0.0240 |
| 61 |
IRRITABLE BOWEL SYNDROME |
512 |
0.0239 |
| 62 |
SENSE OF OPPRESSION |
27 |
0.0229 |
| 63 |
HYPOCHOLESTEROLAEMIA |
8 |
0.0227 |
| 64 |
AUTOIMMUNE DISORDER |
221 |
0.0227 |
| 65 |
AORTIC VALVE CALCIFICATION |
11 |
0.0214 |
| 66 |
JOINT RANGE OF MOTION DECREASED |
279 |
0.0208 |
| 67 |
WOUND INFECTION |
220 |
0.0201 |
| 68 |
PSEUDOMONAL SEPSIS |
34 |
0.0194 |
| 69 |
NEUTROPENIC COLITIS |
40 |
0.0193 |
| 70 |
BURSITIS |
227 |
0.0187 |
| 71 |
GRIP STRENGTH DECREASED |
164 |
0.0186 |
| 72 |
WOUND |
518 |
0.0185 |
| 73 |
LUPUS-LIKE SYNDROME |
168 |
0.0185 |
| 74 |
C-REACTIVE PROTEIN DECREASED |
12 |
0.0184 |
| 75 |
ALOPECIA TOTALIS |
6 |
0.0182 |
| 76 |
HYPERCHOLESTEROLAEMIA |
176 |
0.0182 |
| 77 |
IMPAIRED HEALING |
590 |
0.0180 |
| 78 |
BLOOD FOLATE DECREASED |
13 |
0.0179 |
| 79 |
EXOSTOSIS |
162 |
0.0177 |
| 80 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
566 |
0.0159 |
| 81 |
SERONEGATIVE ARTHRITIS |
18 |
0.0157 |
| 82 |
LIVE BIRTH |
123 |
0.0147 |
| 83 |
HYPOCHLORAEMIA |
17 |
0.0145 |
| 84 |
SCIATICA |
229 |
0.0144 |
| 85 |
HYPERBILIRUBINAEMIA NEONATAL |
8 |
0.0137 |
| 86 |
KLEBSIELLA BACTERAEMIA |
13 |
0.0137 |
| 87 |
HAIR DISORDER |
112 |
0.0136 |
| 88 |
WALKING AID USER |
89 |
0.0135 |
| 89 |
SARS-COV-2 TEST NEGATIVE |
9 |
0.0133 |
| 90 |
CONTRAINDICATED PRODUCT ADMINISTERED |
403 |
0.0133 |
| 91 |
VASCULAR DEVICE INFECTION |
60 |
0.0132 |
| 92 |
FOOT DEFORMITY |
144 |
0.0130 |
| 93 |
LARYNGEAL DISCOMFORT |
8 |
0.0126 |
| 94 |
ALOPECIA AREATA |
22 |
0.0125 |
| 95 |
FEBRILE NEUTROPENIA |
827 |
0.0125 |
| 96 |
TUMOUR PAIN |
16 |
0.0121 |
| 97 |
BLOOD UREA DECREASED |
15 |
0.0121 |
| 98 |
CATHETER SITE RELATED REACTION |
9 |
0.0120 |
| 99 |
STOMATITIS |
713 |
0.0117 |
| 100 |
LOWER LIMB FRACTURE |
225 |
0.0117 |
| 101 |
INFUSION RELATED HYPERSENSITIVITY REACTION |
7 |
0.0116 |
| 102 |
INFUSION RELATED REACTION |
772 |
0.0116 |
| 103 |
PULMONARY FIBROSIS |
223 |
0.0116 |
| 104 |
FIBROMYALGIA |
282 |
0.0116 |
| 105 |
LOWER RESPIRATORY TRACT INFECTION |
520 |
0.0114 |
| 106 |
HAIR COLOUR CHANGES |
134 |
0.0108 |
| 107 |
OBESITY |
171 |
0.0107 |
| 108 |
PALMAR ERYTHEMA |
12 |
0.0104 |
| 109 |
INTESTINAL PSEUDO-OBSTRUCTION |
9 |
0.0102 |
| 110 |
LEFT ATRIAL DILATATION |
13 |
0.0102 |
| 111 |
STREPTOCOCCAL BACTERAEMIA |
11 |
0.0101 |
| 112 |
MADAROSIS |
117 |
0.0101 |
| 113 |
HAIR TEXTURE ABNORMAL |
134 |
0.0100 |
| 114 |
FIXED ERUPTION |
17 |
0.0099 |
| 115 |
HICCUPS |
81 |
0.0099 |
| 116 |
BLISTER |
541 |
0.0096 |
| 117 |
PSYCHOLOGICAL TRAUMA |
83 |
0.0096 |
| 118 |
HEPATOCELLULAR INJURY |
134 |
0.0094 |
| 119 |
COMA HEPATIC |
7 |
0.0094 |
| 120 |
HEPATIC CIRRHOSIS |
175 |
0.0093 |
| 121 |
EYE INJURY |
28 |
0.0092 |
| 122 |
ARTHROPATHY |
511 |
0.0092 |
| 123 |
HEPATIC ENZYME INCREASED |
625 |
0.0092 |
| 124 |
ILL-DEFINED DISORDER |
550 |
0.0090 |
| 125 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
100 |
0.0090 |
| 126 |
DISCOMFORT |
544 |
0.0089 |
| 127 |
PARONYCHIA |
39 |
0.0089 |
| 128 |
CARBON DIOXIDE DECREASED |
10 |
0.0087 |
| 129 |
INFUSION SITE IRRITATION |
11 |
0.0086 |
| 130 |
WEIGHT FLUCTUATION |
89 |
0.0085 |
| 131 |
EOSINOPHIL COUNT DECREASED |
20 |
0.0084 |
| 132 |
LIVER INJURY |
206 |
0.0084 |
| 133 |
ATELECTASIS |
80 |
0.0083 |
| 134 |
JOINT DISLOCATION |
87 |
0.0082 |
| 135 |
TYPE 2 DIABETES MELLITUS |
276 |
0.0082 |
| 136 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
14 |
0.0080 |
| 137 |
THROMBOCYTOPENIC PURPURA |
11 |
0.0080 |
| 138 |
PHARYNGEAL ERYTHEMA |
17 |
0.0080 |
| 139 |
PRESCRIBED OVERDOSE |
155 |
0.0080 |
| 140 |
ABDOMINAL SEPSIS |
7 |
0.0079 |
| 141 |
CYTOLYTIC HEPATITIS |
26 |
0.0078 |
| 142 |
ALVEOLITIS |
11 |
0.0078 |
| 143 |
RADIATION SKIN INJURY |
9 |
0.0078 |
| 144 |
BLOOD CHLORIDE DECREASED |
20 |
0.0077 |
| 145 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
131 |
0.0077 |
| 146 |
PREGNANCY |
154 |
0.0077 |
| 147 |
ENTEROCOLITIS INFECTIOUS |
7 |
0.0076 |
| 148 |
ANORECTAL DISORDER |
15 |
0.0075 |
| 149 |
NIGHT SWEATS |
242 |
0.0075 |
| 150 |
MUCOSAL INFLAMMATION |
195 |
0.0074 |
| 151 |
ENCEPHALOPATHY |
182 |
0.0074 |
| 152 |
ENTERITIS |
47 |
0.0073 |
| 153 |
CEREBELLAR SYNDROME |
16 |
0.0073 |
| 154 |
DIABETIC METABOLIC DECOMPENSATION |
10 |
0.0072 |
| 155 |
BICYTOPENIA |
14 |
0.0071 |
| 156 |
SOFT TISSUE INFECTION |
13 |
0.0071 |
| 157 |
TONIC CONVULSION |
10 |
0.0071 |
| 158 |
LIVER DISORDER |
313 |
0.0071 |
| 159 |
SUBCLAVIAN VEIN THROMBOSIS |
8 |
0.0070 |
| 160 |
POST HERPETIC NEURALGIA |
10 |
0.0070 |
| 161 |
TONGUE COATED |
12 |
0.0069 |
| 162 |
CLONUS |
19 |
0.0069 |
| 163 |
PROTEIN TOTAL DECREASED |
26 |
0.0069 |
| 164 |
GASTROINTESTINAL DISORDER |
607 |
0.0068 |
| 165 |
ROAD TRAFFIC ACCIDENT |
283 |
0.0068 |
| 166 |
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
12 |
0.0067 |
| 167 |
APLASTIC ANAEMIA |
35 |
0.0067 |
| 168 |
BONE MARROW FAILURE |
135 |
0.0066 |
| 169 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
10 |
0.0066 |
| 170 |
DELIRIUM |
227 |
0.0065 |
| 171 |
BODY TEMPERATURE ABNORMAL |
12 |
0.0065 |
| 172 |
INJURY |
458 |
0.0065 |
| 173 |
OTOTOXICITY |
12 |
0.0065 |
| 174 |
FREQUENT BOWEL MOVEMENTS |
172 |
0.0064 |
| 175 |
NEUTROPHIL COUNT DECREASED |
259 |
0.0063 |
| 176 |
HIP ARTHROPLASTY |
97 |
0.0063 |
| 177 |
SLEEP DISORDER |
440 |
0.0062 |
| 178 |
PSORIATIC ARTHROPATHY |
253 |
0.0062 |
| 179 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
7 |
0.0062 |
| 180 |
TONIC CLONIC MOVEMENTS |
8 |
0.0061 |
| 181 |
TOXIC ENCEPHALOPATHY |
31 |
0.0061 |
| 182 |
PELVIC ABSCESS |
7 |
0.0061 |
| 183 |
INFUSION SITE REACTION |
18 |
0.0060 |
| 184 |
CATHETER RELATED INFECTION |
6 |
0.0059 |
| 185 |
SEDATION COMPLICATION |
15 |
0.0059 |
| 186 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
7 |
0.0059 |
| 187 |
GENERAL PHYSICAL HEALTH DETERIORATION |
673 |
0.0058 |
| 188 |
FLUID INTAKE REDUCED |
29 |
0.0058 |
| 189 |
JOINT DESTRUCTION |
9 |
0.0058 |
| 190 |
AXILLARY MASS |
6 |
0.0058 |
| 191 |
SWELLING |
535 |
0.0057 |
| 192 |
CONTUSION |
550 |
0.0057 |
| 193 |
THROMBOPHLEBITIS |
20 |
0.0057 |
| 194 |
EAR INFECTION |
150 |
0.0056 |
| 195 |
METASTASES TO LYMPH NODES |
38 |
0.0056 |
| 196 |
VARICOSE VEIN |
29 |
0.0056 |
| 197 |
KERATITIS |
17 |
0.0056 |
| 198 |
BLEPHAROSPASM |
35 |
0.0056 |
| 199 |
LUNG DISORDER |
272 |
0.0055 |
| 200 |
RED CELL DISTRIBUTION WIDTH INCREASED |
23 |
0.0055 |
| 201 |
OXYGEN THERAPY |
9 |
0.0055 |
| 202 |
WHEEZING |
323 |
0.0054 |
| 203 |
HYPERAMMONAEMIA |
27 |
0.0054 |
| 204 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
241 |
0.0054 |
| 205 |
ENTEROCOLITIS |
31 |
0.0054 |
| 206 |
MALIGNANT PLEURAL EFFUSION |
9 |
0.0053 |
| 207 |
VENOUS THROMBOSIS LIMB |
11 |
0.0053 |
| 208 |
PRESCRIBED UNDERDOSE |
106 |
0.0053 |
| 209 |
CONGENITAL ANOMALY |
41 |
0.0053 |
| 210 |
SINUSITIS |
542 |
0.0053 |
| 211 |
INTESTINAL ISCHAEMIA |
29 |
0.0053 |
| 212 |
C-REACTIVE PROTEIN INCREASED |
191 |
0.0052 |
| 213 |
PUSTULAR PSORIASIS |
18 |
0.0052 |
| 214 |
STAPHYLOCOCCUS TEST POSITIVE |
11 |
0.0052 |
| 215 |
INFLAMMATION |
269 |
0.0052 |
| 216 |
LARYNGOSPASM |
14 |
0.0052 |
| 217 |
AORTIC THROMBOSIS |
6 |
0.0052 |
| 218 |
VULVOVAGINAL CANDIDIASIS |
7 |
0.0052 |
| 219 |
ALLODYNIA |
6 |
0.0051 |
| 220 |
MUCOUS MEMBRANE DISORDER |
7 |
0.0051 |
| 221 |
OSTEOARTHRITIS |
217 |
0.0051 |
| 222 |
ANAPHYLACTOID REACTION |
21 |
0.0051 |
| 223 |
PHLEBITIS |
26 |
0.0051 |
| 224 |
BONE MARROW TOXICITY |
6 |
0.0051 |
| 225 |
HYPOKALAEMIA |
233 |
0.0050 |
| 226 |
LARGE INTESTINE PERFORATION |
35 |
0.0050 |
| 227 |
CHEMOTHERAPY |
19 |
0.0050 |
| 228 |
HYPOALBUMINAEMIA |
39 |
0.0050 |
| 229 |
PERIPHERAL MOTOR NEUROPATHY |
7 |
0.0050 |
| 230 |
WHITE BLOOD CELL COUNT INCREASED |
191 |
0.0050 |
| 231 |
HYPERTHERMIA |
38 |
0.0050 |
| 232 |
BLOOD CHOLESTEROL INCREASED |
232 |
0.0050 |
| 233 |
COLON CANCER METASTATIC |
8 |
0.0050 |
| 234 |
ANAPHYLACTIC SHOCK |
128 |
0.0050 |
| 235 |
RASH MACULO-PAPULAR |
110 |
0.0049 |
| 236 |
DERMATITIS ACNEIFORM |
30 |
0.0049 |
| 237 |
MUSCULOSKELETAL PAIN |
254 |
0.0048 |
| 238 |
HYPOMAGNESAEMIA |
67 |
0.0048 |
| 239 |
GASTROINTESTINAL NECROSIS |
14 |
0.0048 |
| 240 |
FEELING HOT |
292 |
0.0048 |
| 241 |
OEDEMA |
258 |
0.0048 |
| 242 |
GENERALISED ERYTHEMA |
27 |
0.0047 |
| 243 |
RECTAL HAEMORRHAGE |
202 |
0.0047 |
| 244 |
SPONDYLITIS |
17 |
0.0047 |
| 245 |
HYPERSENSITIVITY |
861 |
0.0046 |
| 246 |
ALOPECIA |
906 |
0.0046 |
| 247 |
RHEUMATOID ARTHRITIS |
521 |
0.0046 |
| 248 |
RASH VESICULAR |
22 |
0.0045 |
| 249 |
TUMOUR LYSIS SYNDROME |
40 |
0.0045 |
| 250 |
BLOOD ALBUMIN DECREASED |
36 |
0.0045 |
| 251 |
INFUSION SITE PAIN |
58 |
0.0045 |
| 252 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
58 |
0.0045 |
| 253 |
OESOPHAGITIS |
49 |
0.0045 |
| 254 |
HYPOPHOSPHATAEMIA |
33 |
0.0045 |
| 255 |
INFECTION |
639 |
0.0044 |
| 256 |
VENOOCCLUSIVE DISEASE |
11 |
0.0044 |
| 257 |
EXTRAVASATION |
18 |
0.0044 |
| 258 |
STAPHYLOCOCCAL BACTERAEMIA |
19 |
0.0044 |
| 259 |
GAIT INABILITY |
146 |
0.0044 |
| 260 |
ODYNOPHAGIA |
26 |
0.0044 |
| 261 |
JOINT SWELLING |
525 |
0.0043 |
| 262 |
INTRACRANIAL PRESSURE INCREASED |
24 |
0.0043 |
| 263 |
CRANIOCEREBRAL INJURY |
13 |
0.0043 |
| 264 |
ULCER HAEMORRHAGE |
29 |
0.0043 |
| 265 |
RESPIRATORY DISORDER |
127 |
0.0042 |
| 266 |
COLITIS ULCERATIVE |
189 |
0.0042 |
| 267 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
43 |
0.0042 |
| 268 |
KNEE ARTHROPLASTY |
88 |
0.0042 |
| 269 |
ENTEROBACTER INFECTION |
7 |
0.0042 |
| 270 |
LABORATORY TEST ABNORMAL |
122 |
0.0041 |
| 271 |
FEMALE GENITAL TRACT FISTULA |
7 |
0.0041 |
| 272 |
THROMBOCYTOPENIA |
457 |
0.0041 |
| 273 |
TOXIC SKIN ERUPTION |
41 |
0.0041 |
| 274 |
CONFUSIONAL STATE |
657 |
0.0041 |
| 275 |
JOINT STIFFNESS |
106 |
0.0040 |
| 276 |
HYPOPITUITARISM |
7 |
0.0040 |
| 277 |
AORTIC STENOSIS |
14 |
0.0040 |
| 278 |
ADENOCARCINOMA |
9 |
0.0040 |
| 279 |
PANCREATITIS |
212 |
0.0040 |
| 280 |
BLOOD CULTURE POSITIVE |
12 |
0.0040 |
| 281 |
PANCREATITIS ACUTE |
89 |
0.0040 |
| 282 |
PULMONARY TOXICITY |
28 |
0.0040 |
| 283 |
MOBILITY DECREASED |
284 |
0.0039 |
| 284 |
TONGUE OEDEMA |
15 |
0.0039 |
| 285 |
MATERNAL EXPOSURE DURING PREGNANCY |
350 |
0.0039 |
| 286 |
HYPONATRAEMIA |
221 |
0.0039 |
| 287 |
CANCER PAIN |
10 |
0.0039 |
| 288 |
RENAL TUBULAR DISORDER |
11 |
0.0039 |
| 289 |
NEUTROPHIL COUNT ABNORMAL |
11 |
0.0039 |
| 290 |
ANAPHYLACTIC REACTION |
215 |
0.0039 |
| 291 |
CATHETER SITE PAIN |
10 |
0.0039 |
| 292 |
SUPRAVENTRICULAR EXTRASYSTOLES |
13 |
0.0038 |
| 293 |
GASTROINTESTINAL PERFORATION |
16 |
0.0038 |
| 294 |
BREAST CANCER STAGE II |
32 |
0.0038 |
| 295 |
SUBILEUS |
8 |
0.0038 |
| 296 |
IMMUNE-MEDIATED LUNG DISEASE |
7 |
0.0038 |
| 297 |
LEUKOPENIA |
192 |
0.0038 |
| 298 |
BLOOD PHOSPHORUS DECREASED |
14 |
0.0038 |
| 299 |
TOXIC EPIDERMAL NECROLYSIS |
58 |
0.0038 |
| 300 |
ESCHERICHIA SEPSIS |
11 |
0.0038 |
| 301 |
HYPOXIA |
132 |
0.0037 |
| 302 |
SEPTIC SHOCK |
163 |
0.0037 |
| 303 |
CATHETER SITE ERYTHEMA |
8 |
0.0037 |
| 304 |
CYSTITIS HAEMORRHAGIC |
15 |
0.0037 |
| 305 |
MEDICATION ERROR |
206 |
0.0037 |
| 306 |
INFUSION SITE EXTRAVASATION |
23 |
0.0037 |
| 307 |
PERIPHERAL ISCHAEMIA |
15 |
0.0037 |
| 308 |
CHOLESTASIS |
70 |
0.0036 |
| 309 |
ARTERIAL THROMBOSIS |
7 |
0.0036 |
| 310 |
GASTROINTESTINAL TUBE INSERTION |
9 |
0.0036 |
| 311 |
PERIPHERAL SENSORY NEUROPATHY |
21 |
0.0036 |
| 312 |
BLOOD MAGNESIUM DECREASED |
31 |
0.0036 |
| 313 |
PULSE ABSENT |
17 |
0.0036 |
| 314 |
PYELONEPHRITIS ACUTE |
7 |
0.0036 |
| 315 |
DRY MOUTH |
289 |
0.0036 |
| 316 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
83 |
0.0036 |
| 317 |
EAR PAIN |
69 |
0.0035 |
| 318 |
THROMBOCYTOSIS |
13 |
0.0035 |
| 319 |
ELECTROLYTE IMBALANCE |
41 |
0.0035 |
| 320 |
ABDOMINAL DISCOMFORT |
591 |
0.0035 |
| 321 |
INTERSTITIAL LUNG DISEASE |
170 |
0.0035 |
| 322 |
THERAPY NON-RESPONDER |
157 |
0.0035 |
| 323 |
LUMBAR VERTEBRAL FRACTURE |
16 |
0.0035 |
| 324 |
APHTHOUS ULCER |
27 |
0.0035 |
| 325 |
DISSEMINATED INTRAVASCULAR COAGULATION |
49 |
0.0035 |
| 326 |
OSTEOPOROSIS |
142 |
0.0034 |
| 327 |
IMMUNE-MEDIATED HEPATITIS |
7 |
0.0034 |
| 328 |
TYPE I HYPERSENSITIVITY |
12 |
0.0034 |
| 329 |
STRIDOR |
10 |
0.0034 |
| 330 |
NEUTROPENIA |
461 |
0.0034 |
| 331 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
58 |
0.0034 |
| 332 |
THORACIC VERTEBRAL FRACTURE |
10 |
0.0034 |
| 333 |
PANCYTOPENIA |
188 |
0.0034 |
| 334 |
HAEMOLYTIC ANAEMIA |
30 |
0.0033 |
| 335 |
PYREXIA |
1156 |
0.0033 |
| 336 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
74 |
0.0033 |
| 337 |
PERIPHERAL SWELLING |
514 |
0.0033 |
| 338 |
PULSE ABNORMAL |
8 |
0.0033 |
| 339 |
CEREBRAL VENOUS THROMBOSIS |
6 |
0.0033 |
| 340 |
AMNESIA |
215 |
0.0033 |
| 341 |
FLUSHING |
335 |
0.0033 |
| 342 |
HEPATIC CYTOLYSIS |
42 |
0.0033 |
| 343 |
BRAIN OEDEMA |
41 |
0.0032 |
| 344 |
SPINAL FUSION SURGERY |
13 |
0.0032 |
| 345 |
DRUG INTOLERANCE |
306 |
0.0032 |
| 346 |
DERMATITIS EXFOLIATIVE GENERALISED |
11 |
0.0032 |
| 347 |
MUSCULOSKELETAL STIFFNESS |
275 |
0.0031 |
| 348 |
LIPASE INCREASED |
24 |
0.0031 |
| 349 |
VENTRICULAR DYSFUNCTION |
8 |
0.0031 |
| 350 |
METASTASES TO MENINGES |
7 |
0.0031 |
| 351 |
IMMUNE THROMBOCYTOPENIA |
14 |
0.0031 |
| 352 |
ILEUS |
38 |
0.0031 |
| 353 |
VENOOCCLUSIVE LIVER DISEASE |
15 |
0.0030 |
| 354 |
CARDIOTOXICITY |
27 |
0.0030 |
| 355 |
MUSCLE SPASTICITY |
37 |
0.0030 |
| 356 |
PROTEIN TOTAL INCREASED |
8 |
0.0030 |
| 357 |
CYTOKINE RELEASE SYNDROME |
60 |
0.0030 |
| 358 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
30 |
0.0030 |
| 359 |
HYPERLACTACIDAEMIA |
8 |
0.0030 |
| 360 |
NAIL DISORDER |
26 |
0.0030 |
| 361 |
INFUSION SITE ERYTHEMA |
25 |
0.0030 |
| 362 |
TONGUE ULCERATION |
10 |
0.0030 |
| 363 |
LUNG INFILTRATION |
26 |
0.0029 |
| 364 |
OEDEMA PERIPHERAL |
356 |
0.0029 |
| 365 |
TYPE IV HYPERSENSITIVITY REACTION |
8 |
0.0029 |
| 366 |
HYPOVOLAEMIA |
17 |
0.0029 |
| 367 |
AGRANULOCYTOSIS |
54 |
0.0029 |
| 368 |
CAPILLARY LEAK SYNDROME |
6 |
0.0029 |
| 369 |
MYOSITIS |
26 |
0.0029 |
| 370 |
RASH MORBILLIFORM |
8 |
0.0029 |
| 371 |
NASOPHARYNGITIS |
531 |
0.0029 |
| 372 |
INFUSION SITE SWELLING |
18 |
0.0029 |
| 373 |
EOSINOPHILIC PNEUMONIA |
9 |
0.0029 |
| 374 |
MUSCLE CONTRACTIONS INVOLUNTARY |
10 |
0.0028 |
| 375 |
ABDOMINAL TENDERNESS |
14 |
0.0028 |
| 376 |
IRON DEFICIENCY ANAEMIA |
26 |
0.0028 |
| 377 |
ERYSIPELAS |
14 |
0.0028 |
| 378 |
DERMATITIS BULLOUS |
20 |
0.0028 |
| 379 |
NORMAL NEWBORN |
15 |
0.0028 |
| 380 |
BODY TEMPERATURE INCREASED |
56 |
0.0027 |
| 381 |
WHITE BLOOD CELL COUNT DECREASED |
295 |
0.0027 |
| 382 |
DECREASED APPETITE |
632 |
0.0027 |
| 383 |
IMMUNE-MEDIATED ENTEROCOLITIS |
10 |
0.0027 |
| 384 |
HYPOCALCAEMIA |
51 |
0.0027 |
| 385 |
ADVERSE EVENT |
248 |
0.0027 |
| 386 |
ILEUS PARALYTIC |
12 |
0.0027 |
| 387 |
BLOOD UREA INCREASED |
45 |
0.0027 |
| 388 |
RETINOPATHY |
10 |
0.0027 |
| 389 |
HYPERURICAEMIA |
11 |
0.0027 |
| 390 |
MIXED LIVER INJURY |
8 |
0.0027 |
| 391 |
HEPATITIS CHOLESTATIC |
16 |
0.0027 |
| 392 |
OXYGEN SATURATION DECREASED |
149 |
0.0026 |
| 393 |
ONYCHOMADESIS |
11 |
0.0026 |
| 394 |
TREATMENT FAILURE |
217 |
0.0026 |
| 395 |
DYSAESTHESIA |
8 |
0.0026 |
| 396 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
9 |
0.0026 |
| 397 |
WEIGHT INCREASED |
582 |
0.0026 |
| 398 |
HAEMOLYSIS |
20 |
0.0026 |
| 399 |
ORAL CANDIDIASIS |
34 |
0.0026 |
| 400 |
ABDOMINAL RIGIDITY |
7 |
0.0026 |
| 401 |
PLATELET COUNT DECREASED |
274 |
0.0026 |
| 402 |
RENAL FAILURE ACUTE |
109 |
0.0026 |
| 403 |
JAUNDICE CHOLESTATIC |
9 |
0.0025 |
| 404 |
INJECTION SITE INDURATION |
33 |
0.0025 |
| 405 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
9 |
0.0025 |
| 406 |
COLITIS |
96 |
0.0025 |
| 407 |
PLATELET COUNT INCREASED |
33 |
0.0025 |
| 408 |
SPUTUM DISCOLOURED |
24 |
0.0025 |
| 409 |
HYPERBILIRUBINAEMIA |
26 |
0.0025 |
| 410 |
ENDOTRACHEAL INTUBATION |
7 |
0.0025 |
| 411 |
FAECES SOFT |
18 |
0.0025 |
| 412 |
DEVICE RELATED INFECTION |
38 |
0.0025 |
| 413 |
PANCREATIC CARCINOMA METASTATIC |
7 |
0.0025 |
| 414 |
TUMOUR HAEMORRHAGE |
7 |
0.0025 |
| 415 |
SMALL FOR DATES BABY |
12 |
0.0024 |
| 416 |
DERMATITIS EXFOLIATIVE |
12 |
0.0024 |
| 417 |
BRONCHOSPASM |
34 |
0.0024 |
| 418 |
JAUNDICE |
64 |
0.0024 |
| 419 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
59 |
0.0024 |
| 420 |
FEEDING DISORDER |
48 |
0.0024 |
| 421 |
DYSPEPSIA |
231 |
0.0023 |
| 422 |
VOMITING |
1103 |
0.0023 |
| 423 |
URTICARIA |
389 |
0.0023 |
| 424 |
PULMONARY ALVEOLAR HAEMORRHAGE |
13 |
0.0023 |
| 425 |
EXPOSURE DURING PREGNANCY |
144 |
0.0023 |
| 426 |
VARICES OESOPHAGEAL |
7 |
0.0023 |
| 427 |
ADRENAL INSUFFICIENCY |
28 |
0.0023 |
| 428 |
TACHYCARDIA |
205 |
0.0023 |
| 429 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
7 |
0.0023 |
| 430 |
INTENTIONAL PRODUCT USE ISSUE |
202 |
0.0023 |
| 431 |
IMPAIRED QUALITY OF LIFE |
33 |
0.0023 |
| 432 |
DRUG-INDUCED LIVER INJURY |
72 |
0.0023 |
| 433 |
DYSPNOEA |
1297 |
0.0023 |
| 434 |
PNEUMONITIS |
62 |
0.0023 |
| 435 |
DISABILITY |
45 |
0.0023 |
| 436 |
CHEST PAIN |
421 |
0.0023 |
| 437 |
HYPOTHERMIA |
23 |
0.0023 |
| 438 |
PORTAL HYPERTENSION |
7 |
0.0023 |
| 439 |
GENERAL SYMPTOM |
17 |
0.0023 |
| 440 |
ARTHRITIS |
178 |
0.0023 |
| 441 |
TRANSAMINASES INCREASED |
50 |
0.0022 |
| 442 |
PARAESTHESIA |
353 |
0.0022 |
| 443 |
HYPOAESTHESIA |
335 |
0.0022 |
| 444 |
HYPOPHAGIA |
57 |
0.0022 |
| 445 |
ERYTHEMA |
458 |
0.0022 |
| 446 |
INSOMNIA |
591 |
0.0022 |
| 447 |
RECURRENT CANCER |
9 |
0.0022 |
| 448 |
TRANSFUSION |
23 |
0.0022 |
| 449 |
BACTERAEMIA |
26 |
0.0022 |
| 450 |
EMBOLISM |
18 |
0.0022 |
| 451 |
HYPERTENSION |
457 |
0.0022 |
| 452 |
HYPERTRANSAMINASAEMIA |
15 |
0.0022 |
| 453 |
HYPOVENTILATION |
7 |
0.0021 |
| 454 |
BLOOD BILIRUBIN INCREASED |
58 |
0.0021 |
| 455 |
ORAL PAIN |
48 |
0.0021 |
| 456 |
CACHEXIA |
11 |
0.0021 |
| 457 |
SPINAL PAIN |
25 |
0.0021 |
| 458 |
CANDIDA INFECTION |
36 |
0.0021 |
| 459 |
DEAFNESS NEUROSENSORY |
7 |
0.0021 |
| 460 |
CHOLECYSTITIS ACUTE |
12 |
0.0021 |
| 461 |
INCORRECT DRUG ADMINISTRATION RATE |
9 |
0.0021 |
| 462 |
PLEURAL EFFUSION |
128 |
0.0021 |
| 463 |
POLYNEUROPATHY |
25 |
0.0021 |
| 464 |
ABDOMINAL PAIN |
483 |
0.0021 |
| 465 |
NEOPLASM RECURRENCE |
7 |
0.0021 |
| 466 |
EPILEPSY |
63 |
0.0021 |
| 467 |
EJECTION FRACTION DECREASED |
32 |
0.0021 |
| 468 |
CHEST DISCOMFORT |
210 |
0.0020 |
| 469 |
HYPERTRIGLYCERIDAEMIA |
12 |
0.0020 |
| 470 |
HEPATIC FIBROSIS |
7 |
0.0020 |
| 471 |
RENAL TUBULAR NECROSIS |
20 |
0.0020 |
| 472 |
VULVOVAGINAL MYCOTIC INFECTION |
8 |
0.0020 |
| 473 |
RASH |
883 |
0.0020 |
| 474 |
SINUS HEADACHE |
12 |
0.0020 |
| 475 |
ORGANISING PNEUMONIA |
10 |
0.0020 |
| 476 |
HEPATIC FUNCTION ABNORMAL |
75 |
0.0020 |
| 477 |
ASPIRATION |
22 |
0.0020 |
| 478 |
PRURITUS |
770 |
0.0020 |
| 479 |
ASTHMA |
226 |
0.0020 |
| 480 |
SKIN FISSURES |
39 |
0.0020 |
| 481 |
BLEPHARITIS |
8 |
0.0020 |
| 482 |
PAPILLOEDEMA |
9 |
0.0020 |
| 483 |
OROPHARYNGEAL DISCOMFORT |
18 |
0.0020 |
| 484 |
SUSPECTED OFF LABEL USE |
9 |
0.0020 |
| 485 |
ANAEMIA |
379 |
0.0020 |
| 486 |
NEUROPATHY PERIPHERAL |
189 |
0.0020 |
| 487 |
MUSCULAR WEAKNESS |
225 |
0.0020 |
| 488 |
LYMPHOPENIA |
28 |
0.0020 |
| 489 |
ANURIA |
17 |
0.0020 |
| 490 |
MALNUTRITION |
22 |
0.0020 |
| 491 |
NEUTROPENIC SEPSIS |
14 |
0.0020 |
| 492 |
ACUTE PULMONARY OEDEMA |
11 |
0.0020 |
| 493 |
CHEST X-RAY ABNORMAL |
6 |
0.0020 |
| 494 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
17 |
0.0020 |
| 495 |
LOCALISED OEDEMA |
9 |
0.0019 |
| 496 |
LEFT VENTRICULAR DYSFUNCTION |
13 |
0.0019 |
| 497 |
ALTERED STATE OF CONSCIOUSNESS |
42 |
0.0019 |
| 498 |
UNRESPONSIVE TO STIMULI |
50 |
0.0019 |
| 499 |
GENERALISED TONIC-CLONIC SEIZURE |
32 |
0.0019 |
| 500 |
RESPIRATORY DISTRESS |
53 |
0.0019 |
| 501 |
ABDOMINAL PAIN UPPER |
395 |
0.0019 |
| 502 |
TONSILLITIS |
10 |
0.0019 |
| 503 |
CYANOSIS |
30 |
0.0019 |
| 504 |
THROAT TIGHTNESS |
51 |
0.0019 |
| 505 |
NAUSEA |
1490 |
0.0019 |
| 506 |
NON-SMALL CELL LUNG CANCER |
9 |
0.0019 |
| 507 |
GASTROINTESTINAL TOXICITY |
9 |
0.0019 |
| 508 |
INTESTINAL PERFORATION |
21 |
0.0019 |
| 509 |
SINUS BRADYCARDIA |
18 |
0.0019 |
| 510 |
MYOCARDIAL ISCHAEMIA |
21 |
0.0018 |
| 511 |
BACTERIAL SEPSIS |
6 |
0.0018 |
| 512 |
ASCITES |
54 |
0.0018 |
| 513 |
ACUTE KIDNEY INJURY |
281 |
0.0018 |
| 514 |
BREATH SOUNDS ABNORMAL |
9 |
0.0018 |
| 515 |
STAPHYLOCOCCAL SEPSIS |
9 |
0.0018 |
| 516 |
PETECHIAE |
19 |
0.0018 |
| 517 |
LIVER FUNCTION TEST INCREASED |
39 |
0.0018 |
| 518 |
HYPERNATRAEMIA |
9 |
0.0018 |
| 519 |
DRUG ERUPTION |
32 |
0.0018 |
| 520 |
SEPSIS |
201 |
0.0018 |
| 521 |
CARDIAC FAILURE ACUTE |
12 |
0.0018 |
| 522 |
RHINOVIRUS INFECTION |
7 |
0.0018 |
| 523 |
MULTI-ORGAN FAILURE |
31 |
0.0018 |
| 524 |
MIGRAINE |
171 |
0.0018 |
| 525 |
COLITIS ISCHAEMIC |
12 |
0.0018 |
| 526 |
CHOLANGITIS |
11 |
0.0018 |
| 527 |
CLOSTRIDIAL INFECTION |
6 |
0.0018 |
| 528 |
POLYDIPSIA |
7 |
0.0018 |
| 529 |
SKIN TOXICITY |
10 |
0.0018 |
| 530 |
DEHYDRATION |
236 |
0.0018 |
| 531 |
NEUROTOXICITY |
31 |
0.0018 |
| 532 |
PNEUMOTHORAX |
28 |
0.0018 |
| 533 |
PETIT MAL EPILEPSY |
9 |
0.0018 |
| 534 |
SINUS TACHYCARDIA |
25 |
0.0018 |
| 535 |
LYMPHOCYTE COUNT DECREASED |
31 |
0.0018 |
| 536 |
PRODUCT COLOUR ISSUE |
9 |
0.0018 |
| 537 |
APLASIA PURE RED CELL |
6 |
0.0017 |
| 538 |
DIARRHOEA |
1125 |
0.0017 |
| 539 |
RHINITIS |
14 |
0.0017 |
| 540 |
LYMPHOEDEMA |
12 |
0.0017 |
| 541 |
CONDITION AGGRAVATED |
527 |
0.0017 |
| 542 |
TASTE DISORDER |
35 |
0.0017 |
| 543 |
MEMORY IMPAIRMENT |
237 |
0.0017 |
| 544 |
METABOLIC ACIDOSIS |
55 |
0.0017 |
| 545 |
HAEMATOCRIT DECREASED |
34 |
0.0017 |
| 546 |
POLYARTHRITIS |
9 |
0.0017 |
| 547 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
82 |
0.0017 |
| 548 |
METASTASES TO LIVER |
30 |
0.0017 |
| 549 |
SERUM FERRITIN INCREASED |
9 |
0.0017 |
| 550 |
SUDDEN DEATH |
18 |
0.0017 |
| 551 |
CARDIO-RESPIRATORY ARREST |
71 |
0.0017 |
| 552 |
BLOOD SODIUM DECREASED |
32 |
0.0017 |
| 553 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
30 |
0.0017 |
| 554 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
10 |
0.0017 |
| 555 |
SUPRAVENTRICULAR TACHYCARDIA |
16 |
0.0017 |
| 556 |
ADVERSE REACTION |
22 |
0.0017 |
| 557 |
HEPATITIS |
42 |
0.0016 |
| 558 |
HEPATIC PAIN |
7 |
0.0016 |
| 559 |
HAEMORRHOIDAL HAEMORRHAGE |
8 |
0.0016 |
| 560 |
RESPIRATORY DEPRESSION |
20 |
0.0016 |
| 561 |
AMYLASE INCREASED |
6 |
0.0016 |
| 562 |
ISCHAEMIC STROKE |
29 |
0.0016 |
| 563 |
STREPTOCOCCAL INFECTION |
9 |
0.0016 |
| 564 |
ACUTE RESPIRATORY FAILURE |
31 |
0.0016 |
| 565 |
CLOSTRIDIUM DIFFICILE COLITIS |
17 |
0.0016 |
| 566 |
FACE OEDEMA |
27 |
0.0016 |
| 567 |
DEEP VEIN THROMBOSIS |
104 |
0.0016 |
| 568 |
VEIN DISORDER |
8 |
0.0016 |
| 569 |
BACK PAIN |
371 |
0.0016 |
| 570 |
HYPOTENSION |
320 |
0.0016 |
| 571 |
ASTHENIA |
598 |
0.0016 |
| 572 |
UNDERDOSE |
116 |
0.0016 |
| 573 |
PULMONARY EMBOLISM |
151 |
0.0016 |
| 574 |
DRUG TOLERANCE |
8 |
0.0016 |
| 575 |
ESCHERICHIA INFECTION |
13 |
0.0016 |
| 576 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
25 |
0.0016 |
| 577 |
HYPERGLYCAEMIA |
57 |
0.0016 |
| 578 |
ASPARTATE AMINOTRANSFERASE INCREASED |
83 |
0.0016 |
| 579 |
CHILLS |
183 |
0.0016 |
| 580 |
MENINGITIS ASEPTIC |
7 |
0.0016 |
| 581 |
HEPATIC STEATOSIS |
29 |
0.0016 |
| 582 |
PROCTALGIA |
10 |
0.0016 |
| 583 |
CEREBRAL INFARCTION |
38 |
0.0016 |
| 584 |
TACHYPNOEA |
21 |
0.0015 |
| 585 |
SMALL INTESTINAL OBSTRUCTION |
19 |
0.0015 |
| 586 |
FAILURE TO THRIVE |
8 |
0.0015 |
| 587 |
BLOOD PRESSURE SYSTOLIC DECREASED |
7 |
0.0015 |
| 588 |
ARTHRALGIA |
637 |
0.0015 |
| 589 |
HYPOGAMMAGLOBULINAEMIA |
10 |
0.0015 |
| 590 |
FISTULA |
17 |
0.0015 |
| 591 |
BLOOD CALCIUM DECREASED |
17 |
0.0015 |
| 592 |
ERYTHEMA MULTIFORME |
14 |
0.0015 |
| 593 |
FLANK PAIN |
14 |
0.0015 |
| 594 |
WEIGHT DECREASED |
408 |
0.0015 |
| 595 |
HYPOVOLAEMIC SHOCK |
7 |
0.0015 |
| 596 |
LARYNGEAL OEDEMA |
9 |
0.0015 |
| 597 |
PIGMENTATION DISORDER |
9 |
0.0015 |
| 598 |
PRODUCT USE ISSUE |
273 |
0.0015 |
| 599 |
RASH PRURITIC |
78 |
0.0014 |
| 600 |
FATIGUE |
1110 |
0.0014 |
| 601 |
RESTLESSNESS |
52 |
0.0014 |
| 602 |
DUODENAL ULCER |
10 |
0.0014 |
| 603 |
PNEUMONIA |
458 |
0.0014 |
| 604 |
MUSCLE SPASMS |
259 |
0.0014 |
| 605 |
MALIGNANT NEOPLASM PROGRESSION |
144 |
0.0014 |
| 606 |
CONSTIPATION |
306 |
0.0014 |
| 607 |
TORSADE DE POINTES |
11 |
0.0014 |
| 608 |
RED BLOOD CELL COUNT DECREASED |
40 |
0.0014 |
| 609 |
BREAST CANCER METASTATIC |
15 |
0.0014 |
| 610 |
DRUG INTERACTION |
221 |
0.0014 |
| 611 |
UPPER RESPIRATORY TRACT INFECTION |
64 |
0.0014 |
| 612 |
PYELONEPHRITIS |
12 |
0.0014 |
| 613 |
VULVOVAGINAL PRURITUS |
7 |
0.0014 |
| 614 |
RASH PUSTULAR |
10 |
0.0014 |
| 615 |
URINE OUTPUT DECREASED |
12 |
0.0014 |
| 616 |
HAEMATURIA |
47 |
0.0014 |
| 617 |
VISUAL IMPAIRMENT |
169 |
0.0014 |
| 618 |
RETCHING |
29 |
0.0014 |
| 619 |
ALANINE AMINOTRANSFERASE INCREASED |
83 |
0.0014 |
| 620 |
DISEASE PROGRESSION |
159 |
0.0013 |
| 621 |
HYDRONEPHROSIS |
10 |
0.0013 |
| 622 |
ANAL INCONTINENCE |
12 |
0.0013 |
| 623 |
STATUS EPILEPTICUS |
15 |
0.0013 |
| 624 |
MALAISE |
579 |
0.0013 |
| 625 |
GENERALISED OEDEMA |
16 |
0.0013 |
| 626 |
OLIGURIA |
8 |
0.0013 |
| 627 |
BACK INJURY |
14 |
0.0013 |
| 628 |
HYDROCEPHALUS |
7 |
0.0013 |
| 629 |
BLOOD CREATININE INCREASED |
83 |
0.0013 |
| 630 |
RESPIRATORY TRACT INFECTION |
33 |
0.0013 |
| 631 |
DYSPHAGIA |
120 |
0.0013 |
| 632 |
MYOCLONUS |
15 |
0.0013 |
| 633 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
12 |
0.0013 |
| 634 |
PERITONITIS |
26 |
0.0013 |
| 635 |
PERICARDIAL EFFUSION |
29 |
0.0013 |
| 636 |
NEUROLOGICAL SYMPTOM |
7 |
0.0012 |
| 637 |
HAEMATEMESIS |
31 |
0.0012 |
| 638 |
ANXIETY |
348 |
0.0012 |
| 639 |
DYSARTHRIA |
46 |
0.0012 |
| 640 |
MYOCARDITIS |
14 |
0.0012 |
| 641 |
SYNCOPE |
122 |
0.0012 |
| 642 |
EYELID OEDEMA |
14 |
0.0012 |
| 643 |
MYELOSUPPRESSION |
43 |
0.0012 |
| 644 |
ATRIAL FIBRILLATION |
116 |
0.0012 |
| 645 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
6 |
0.0012 |
| 646 |
HEMIPARESIS |
20 |
0.0012 |
| 647 |
HYPERHIDROSIS |
152 |
0.0012 |
| 648 |
PARAESTHESIA ORAL |
17 |
0.0012 |
| 649 |
HYPERTHYROIDISM |
17 |
0.0012 |
| 650 |
SHOCK |
27 |
0.0012 |
| 651 |
RASH ERYTHEMATOUS |
56 |
0.0012 |
| 652 |
CEREBRAL ISCHAEMIA |
6 |
0.0012 |
| 653 |
BONE PAIN |
68 |
0.0012 |
| 654 |
SEIZURE |
134 |
0.0012 |
| 655 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
9 |
0.0012 |
| 656 |
METASTASES TO BONE |
19 |
0.0012 |
| 657 |
PRODUCT USE IN UNAPPROVED INDICATION |
286 |
0.0012 |
| 658 |
TENDERNESS |
12 |
0.0012 |
| 659 |
DEPRESSION |
258 |
0.0011 |
| 660 |
HYPERCALCAEMIA |
14 |
0.0011 |
| 661 |
CONJUNCTIVITIS |
21 |
0.0011 |
| 662 |
EATING DISORDER |
24 |
0.0011 |
| 663 |
METASTASES TO LUNG |
13 |
0.0011 |
| 664 |
NASAL DRYNESS |
7 |
0.0011 |
| 665 |
HOSPICE CARE |
11 |
0.0011 |
| 666 |
ADVERSE DRUG REACTION |
100 |
0.0011 |
| 667 |
PHARYNGITIS STREPTOCOCCAL |
12 |
0.0011 |
| 668 |
PAIN |
677 |
0.0011 |
| 669 |
LUNG INFECTION |
17 |
0.0011 |
| 670 |
COMA |
52 |
0.0011 |
| 671 |
PNEUMONIA BACTERIAL |
10 |
0.0011 |
| 672 |
CHOKING SENSATION |
6 |
0.0011 |
| 673 |
INTESTINAL OBSTRUCTION |
41 |
0.0011 |
| 674 |
OVARIAN CANCER |
10 |
0.0011 |
| 675 |
MENTAL STATUS CHANGES |
30 |
0.0011 |
| 676 |
HEPATITIS ACUTE |
7 |
0.0011 |
| 677 |
SKIN INFECTION |
12 |
0.0011 |
| 678 |
RESPIRATORY FAILURE |
78 |
0.0011 |
| 679 |
CONVULSION |
61 |
0.0011 |
| 680 |
APHASIA |
32 |
0.0011 |
| 681 |
CIRCULATORY COLLAPSE |
18 |
0.0011 |
| 682 |
EPISTAXIS |
79 |
0.0011 |
| 683 |
PROTEINURIA |
20 |
0.0011 |
| 684 |
TROPONIN INCREASED |
8 |
0.0011 |
| 685 |
GAIT DISTURBANCE |
201 |
0.0010 |
| 686 |
MENINGITIS |
7 |
0.0010 |
| 687 |
PHARYNGITIS |
13 |
0.0010 |
| 688 |
BACK DISORDER |
17 |
0.0010 |
| 689 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
41 |
0.0010 |
| 690 |
GENERAL PHYSICAL CONDITION ABNORMAL |
7 |
0.0010 |
| 691 |
OFF LABEL USE |
897 |
0.0010 |
| 692 |
PURPURA |
9 |
0.0010 |
| 693 |
PAIN IN EXTREMITY |
298 |
0.0010 |
| 694 |
AUTOIMMUNE HEPATITIS |
7 |
0.0010 |
| 695 |
HYPERKALAEMIA |
35 |
0.0010 |
| 696 |
NEURALGIA |
24 |
0.0010 |
| 697 |
HAEMOGLOBIN DECREASED |
101 |
0.0010 |
| 698 |
SHOCK HAEMORRHAGIC |
8 |
0.0010 |
| 699 |
BLOOD PRESSURE DECREASED |
65 |
0.0010 |
| 700 |
NEOPLASM PROGRESSION |
34 |
0.0010 |
| 701 |
NEUTROPHIL COUNT INCREASED |
10 |
0.0010 |
| 702 |
PHARYNGEAL OEDEMA |
15 |
0.0010 |
| 703 |
COUGH |
273 |
0.0010 |
| 704 |
MITRAL VALVE INCOMPETENCE |
11 |
0.0010 |
| 705 |
VENTRICULAR EXTRASYSTOLES |
10 |
0.0010 |
| 706 |
PNEUMONIA ASPIRATION |
24 |
0.0010 |
| 707 |
EOSINOPHIL COUNT INCREASED |
8 |
0.0010 |
| 708 |
PALLOR |
26 |
0.0010 |
| 709 |
DERMATITIS |
20 |
0.0010 |
| 710 |
PRESYNCOPE |
23 |
0.0009 |
| 711 |
DIZZINESS |
470 |
0.0009 |
| 712 |
COLON CANCER |
14 |
0.0009 |
| 713 |
CARDIAC FAILURE |
75 |
0.0009 |
| 714 |
BLOOD POTASSIUM DECREASED |
28 |
0.0009 |
| 715 |
CHOLECYSTITIS |
11 |
0.0009 |
| 716 |
ACIDOSIS |
7 |
0.0009 |
| 717 |
ASPERGILLUS INFECTION |
6 |
0.0009 |
| 718 |
EOSINOPHILIA |
16 |
0.0009 |
| 719 |
BACTERIAL INFECTION |
17 |
0.0009 |
| 720 |
NO ADVERSE EVENT |
165 |
0.0009 |
| 721 |
COLD SWEAT |
16 |
0.0009 |
| 722 |
STEVENS-JOHNSON SYNDROME |
20 |
0.0009 |
| 723 |
APNOEA |
7 |
0.0009 |
| 724 |
ECZEMA |
47 |
0.0009 |
| 725 |
GASTROINTESTINAL INFECTION |
8 |
0.0009 |
| 726 |
PRODUCT PHYSICAL ISSUE |
18 |
0.0009 |
| 727 |
DYSGEUSIA |
66 |
0.0009 |
| 728 |
RASH GENERALISED |
23 |
0.0009 |
| 729 |
LEUKOCYTOSIS |
16 |
0.0009 |
| 730 |
MOTOR DYSFUNCTION |
9 |
0.0009 |
| 731 |
ATRIAL FLUTTER |
7 |
0.0009 |
| 732 |
IMMUNODEFICIENCY |
13 |
0.0009 |
| 733 |
UTERINE CANCER |
7 |
0.0009 |
| 734 |
GASTROOESOPHAGEAL REFLUX DISEASE |
70 |
0.0009 |
| 735 |
BRADYCARDIA |
46 |
0.0009 |
| 736 |
MELAENA |
19 |
0.0009 |
| 737 |
SPLENOMEGALY |
10 |
0.0009 |
| 738 |
ANOREXIA |
11 |
0.0009 |
| 739 |
INCONTINENCE |
9 |
0.0009 |
| 740 |
HYPOTHYROIDISM |
27 |
0.0008 |
| 741 |
HAEMATOTOXICITY |
8 |
0.0008 |
| 742 |
LOSS OF CONSCIOUSNESS |
107 |
0.0008 |
| 743 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
14 |
0.0008 |
| 744 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
59 |
0.0008 |
| 745 |
HEADACHE |
519 |
0.0008 |
| 746 |
PRODUCT PREPARATION ERROR |
17 |
0.0008 |
| 747 |
PELVIC PAIN |
15 |
0.0008 |
| 748 |
CLOSTRIDIUM DIFFICILE INFECTION |
18 |
0.0008 |
| 749 |
GASTROENTERITIS |
12 |
0.0008 |
| 750 |
THROMBOTIC MICROANGIOPATHY |
8 |
0.0008 |
| 751 |
HAEMORRHOIDS |
16 |
0.0008 |
| 752 |
CYTOPENIA |
10 |
0.0008 |
| 753 |
HAEMATOCHEZIA |
45 |
0.0008 |
| 754 |
CARDIOMEGALY |
10 |
0.0008 |
| 755 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
23 |
0.0008 |
| 756 |
LOCAL SWELLING |
14 |
0.0008 |
| 757 |
NEPHROPATHY TOXIC |
9 |
0.0008 |
| 758 |
RENAL IMPAIRMENT |
67 |
0.0008 |
| 759 |
HAEMOPTYSIS |
22 |
0.0008 |
| 760 |
DYSURIA |
29 |
0.0008 |
| 761 |
SKIN REACTION |
11 |
0.0008 |
| 762 |
CARDIAC ARREST |
64 |
0.0008 |
| 763 |
BRONCHOPULMONARY ASPERGILLOSIS |
6 |
0.0008 |
| 764 |
SKIN LESION |
21 |
0.0008 |
| 765 |
RENAL FAILURE |
101 |
0.0008 |
| 766 |
DISORIENTATION |
30 |
0.0008 |
| 767 |
PRODUCTIVE COUGH |
36 |
0.0008 |
| 768 |
ELECTROCARDIOGRAM QT PROLONGED |
27 |
0.0007 |
| 769 |
BLOOD PRESSURE FLUCTUATION |
18 |
0.0007 |
| 770 |
DIARRHOEA HAEMORRHAGIC |
7 |
0.0007 |
| 771 |
OROPHARYNGEAL PAIN |
68 |
0.0007 |
| 772 |
ANGINA PECTORIS |
21 |
0.0007 |
| 773 |
INCREASED APPETITE |
14 |
0.0007 |
| 774 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
52 |
0.0007 |
| 775 |
HEPATIC FAILURE |
22 |
0.0007 |
| 776 |
BRONCHITIS |
54 |
0.0007 |
| 777 |
INJECTION SITE EXTRAVASATION |
9 |
0.0007 |
| 778 |
GASTRITIS |
19 |
0.0007 |
| 779 |
URINARY RETENTION |
24 |
0.0007 |
| 780 |
HEPATOMEGALY |
7 |
0.0007 |
| 781 |
BODY TEMPERATURE DECREASED |
7 |
0.0007 |
| 782 |
DERMATITIS CONTACT |
8 |
0.0007 |
| 783 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
18 |
0.0007 |
| 784 |
CARDIOGENIC SHOCK |
10 |
0.0007 |
| 785 |
TINNITUS |
32 |
0.0007 |
| 786 |
FULL BLOOD COUNT DECREASED |
14 |
0.0007 |
| 787 |
PLASMA CELL MYELOMA |
27 |
0.0007 |
| 788 |
HEPATOTOXICITY |
15 |
0.0007 |
| 789 |
ABDOMINAL PAIN LOWER |
17 |
0.0007 |
| 790 |
CEREBRAL HAEMORRHAGE |
24 |
0.0007 |
| 791 |
THROAT IRRITATION |
30 |
0.0007 |
| 792 |
STAPHYLOCOCCAL INFECTION |
22 |
0.0007 |
| 793 |
SINUS CONGESTION |
9 |
0.0007 |
| 794 |
HYPOAESTHESIA ORAL |
10 |
0.0007 |
| 795 |
TREATMENT NONCOMPLIANCE |
36 |
0.0007 |
| 796 |
MUSCULOSKELETAL CHEST PAIN |
10 |
0.0006 |
| 797 |
ACUTE MYOCARDIAL INFARCTION |
19 |
0.0006 |
| 798 |
PRODUCT PRESCRIBING ISSUE |
14 |
0.0006 |
| 799 |
URINARY INCONTINENCE |
19 |
0.0006 |
| 800 |
VERTIGO |
39 |
0.0006 |
| 801 |
HOT FLUSH |
48 |
0.0006 |
| 802 |
VENTRICULAR FIBRILLATION |
7 |
0.0006 |
| 803 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 804 |
ABSCESS |
10 |
0.0006 |
| 805 |
NECK PAIN |
35 |
0.0006 |
| 806 |
HEART RATE INCREASED |
62 |
0.0006 |
| 807 |
LETHARGY |
36 |
0.0006 |
| 808 |
MENTAL IMPAIRMENT |
15 |
0.0006 |
| 809 |
HYPOGLYCAEMIA |
30 |
0.0006 |
| 810 |
DIVERTICULITIS |
17 |
0.0006 |
| 811 |
PULMONARY CONGESTION |
8 |
0.0006 |
| 812 |
PULMONARY MASS |
9 |
0.0006 |
| 813 |
VASCULITIS |
7 |
0.0006 |
| 814 |
SKIN DISORDER |
20 |
0.0006 |
| 815 |
INTERNATIONAL NORMALISED RATIO INCREASED |
17 |
0.0006 |
| 816 |
FLUID RETENTION |
30 |
0.0006 |
| 817 |
PANCREATIC CARCINOMA |
17 |
0.0006 |
| 818 |
DRUG TOXICITY |
8 |
0.0006 |
| 819 |
ACUTE HEPATIC FAILURE |
8 |
0.0006 |
| 820 |
CORONARY ARTERY OCCLUSION |
8 |
0.0006 |
| 821 |
LYMPHOMA |
9 |
0.0006 |
| 822 |
DEATH |
500 |
0.0006 |
| 823 |
BLOOD URINE PRESENT |
11 |
0.0006 |
| 824 |
HAEMATOMA |
15 |
0.0006 |
| 825 |
GASTRIC ULCER |
11 |
0.0006 |
| 826 |
ACUTE MYELOID LEUKAEMIA |
9 |
0.0006 |
| 827 |
NO THERAPEUTIC RESPONSE |
7 |
0.0006 |
| 828 |
MOUTH ULCERATION |
12 |
0.0006 |
| 829 |
TRANSIENT ISCHAEMIC ATTACK |
19 |
0.0006 |
| 830 |
AGEUSIA |
14 |
0.0006 |
| 831 |
SENSORY DISTURBANCE |
9 |
0.0006 |
| 832 |
THIRST |
10 |
0.0006 |
| 833 |
DRUG ADMINISTRATION ERROR |
17 |
0.0006 |
| 834 |
TOOTHACHE |
10 |
0.0006 |
| 835 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
20 |
0.0005 |
| 836 |
ARRHYTHMIA |
26 |
0.0005 |
| 837 |
MYDRIASIS |
7 |
0.0005 |
| 838 |
SWOLLEN TONGUE |
17 |
0.0005 |
| 839 |
DRUG LEVEL INCREASED |
9 |
0.0005 |
| 840 |
ANGIOEDEMA |
24 |
0.0005 |
| 841 |
DIABETIC KETOACIDOSIS |
13 |
0.0005 |
| 842 |
GASTROINTESTINAL HAEMORRHAGE |
45 |
0.0005 |
| 843 |
LYMPHADENOPATHY |
19 |
0.0005 |
| 844 |
ABDOMINAL DISTENSION |
56 |
0.0005 |
| 845 |
TUBULOINTERSTITIAL NEPHRITIS |
10 |
0.0005 |
| 846 |
DYSPNOEA EXERTIONAL |
20 |
0.0005 |
| 847 |
ERUCTATION |
10 |
0.0005 |
| 848 |
LIVER FUNCTION TEST ABNORMAL |
15 |
0.0005 |
| 849 |
HOSPITALISATION |
79 |
0.0005 |
| 850 |
TREMOR |
85 |
0.0005 |
| 851 |
THERAPEUTIC RESPONSE DECREASED |
31 |
0.0005 |
| 852 |
LUNG NEOPLASM MALIGNANT |
21 |
0.0005 |
| 853 |
PERIPHERAL COLDNESS |
7 |
0.0005 |
| 854 |
DIABETES MELLITUS INADEQUATE CONTROL |
9 |
0.0005 |
| 855 |
PRODUCT QUALITY ISSUE |
69 |
0.0005 |
| 856 |
ATAXIA |
6 |
0.0005 |
| 857 |
MASS |
7 |
0.0005 |
| 858 |
THROMBOSIS |
40 |
0.0005 |
| 859 |
SEDATION |
13 |
0.0005 |
| 860 |
BLOOD POTASSIUM INCREASED |
8 |
0.0005 |
| 861 |
RASH PAPULAR |
11 |
0.0005 |
| 862 |
EMOTIONAL DISTRESS |
59 |
0.0005 |
| 863 |
PHOTOSENSITIVITY REACTION |
8 |
0.0005 |
| 864 |
MYELODYSPLASTIC SYNDROME |
7 |
0.0005 |
| 865 |
URINARY TRACT INFECTION |
82 |
0.0005 |
| 866 |
PHOTOPHOBIA |
9 |
0.0005 |
| 867 |
BLOOD PRESSURE INCREASED |
73 |
0.0005 |
| 868 |
SWELLING FACE |
31 |
0.0005 |
| 869 |
CARDIOMYOPATHY |
7 |
0.0005 |
| 870 |
RESPIRATORY ARREST |
13 |
0.0005 |
| 871 |
MYALGIA |
80 |
0.0005 |
| 872 |
PREMATURE BABY |
14 |
0.0005 |
| 873 |
LACRIMATION INCREASED |
14 |
0.0005 |
| 874 |
PRURITUS GENERALISED |
10 |
0.0005 |
| 875 |
BLOOD COUNT ABNORMAL |
7 |
0.0005 |
| 876 |
PALPITATIONS |
54 |
0.0005 |
| 877 |
ORTHOSTATIC HYPOTENSION |
8 |
0.0005 |
| 878 |
SOMNOLENCE |
92 |
0.0005 |
| 879 |
CELLULITIS |
23 |
0.0005 |
| 880 |
RHABDOMYOLYSIS |
19 |
0.0005 |
| 881 |
HYPERSOMNIA |
13 |
0.0005 |
| 882 |
VISUAL ACUITY REDUCED |
15 |
0.0005 |
| 883 |
RENAL DISORDER |
21 |
0.0005 |
| 884 |
NEOPLASM MALIGNANT |
30 |
0.0004 |
| 885 |
GOUT |
8 |
0.0004 |
| 886 |
VISION BLURRED |
61 |
0.0004 |
| 887 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
13 |
0.0004 |
| 888 |
BURNING SENSATION |
31 |
0.0004 |
| 889 |
PREMATURE DELIVERY |
7 |
0.0004 |
| 890 |
FEELING ABNORMAL |
104 |
0.0004 |
| 891 |
MUSCLE TWITCHING |
10 |
0.0004 |
| 892 |
FOETAL EXPOSURE DURING PREGNANCY |
35 |
0.0004 |
| 893 |
RASH MACULAR |
15 |
0.0004 |
| 894 |
DRY SKIN |
57 |
0.0004 |
| 895 |
MANIA |
7 |
0.0004 |
| 896 |
DIPLOPIA |
11 |
0.0004 |
| 897 |
LIP SWELLING |
14 |
0.0004 |
| 898 |
COAGULOPATHY |
7 |
0.0004 |
| 899 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
12 |
0.0004 |
| 900 |
MUSCULOSKELETAL DISCOMFORT |
7 |
0.0004 |
| 901 |
TOOTH DISORDER |
9 |
0.0004 |
| 902 |
PULMONARY OEDEMA |
18 |
0.0004 |
| 903 |
HEAD DISCOMFORT |
7 |
0.0004 |
| 904 |
PRODUCT AVAILABILITY ISSUE |
9 |
0.0004 |
| 905 |
FEELING COLD |
11 |
0.0004 |
| 906 |
DYSPHONIA |
23 |
0.0004 |
| 907 |
BLINDNESS |
16 |
0.0004 |
| 908 |
SKIN EXFOLIATION |
33 |
0.0004 |
| 909 |
GASTROENTERITIS VIRAL |
7 |
0.0004 |
| 910 |
HERPES ZOSTER |
22 |
0.0004 |
| 911 |
BRAIN FOG |
6 |
0.0004 |
| 912 |
DRUG DOSE OMISSION |
63 |
0.0004 |
| 913 |
HALLUCINATION, VISUAL |
8 |
0.0004 |
| 914 |
PRODUCT PRESCRIBING ERROR |
9 |
0.0004 |
| 915 |
CYSTITIS |
12 |
0.0004 |
| 916 |
THERAPY CESSATION |
19 |
0.0004 |
| 917 |
SKIN DISCOLOURATION |
17 |
0.0004 |
| 918 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
20 |
0.0004 |
| 919 |
OSTEONECROSIS OF JAW |
9 |
0.0004 |
| 920 |
POLLAKIURIA |
15 |
0.0004 |
| 921 |
COVID-19 |
63 |
0.0004 |
| 922 |
BLOOD PRESSURE SYSTOLIC INCREASED |
7 |
0.0004 |
| 923 |
ACCIDENTAL OVERDOSE |
13 |
0.0004 |
| 924 |
AGITATION |
26 |
0.0004 |
| 925 |
PAIN IN JAW |
10 |
0.0004 |
| 926 |
PSORIASIS |
46 |
0.0004 |
| 927 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
63 |
0.0003 |
| 928 |
DEAFNESS |
9 |
0.0003 |
| 929 |
OCULAR HYPERAEMIA |
16 |
0.0003 |
| 930 |
PULMONARY HYPERTENSION |
7 |
0.0003 |
| 931 |
CHOLELITHIASIS |
11 |
0.0003 |
| 932 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
11 |
0.0003 |
| 933 |
SPEECH DISORDER |
17 |
0.0003 |
| 934 |
FAECES DISCOLOURED |
7 |
0.0003 |
| 935 |
DEPRESSED MOOD |
17 |
0.0003 |
| 936 |
INCORRECT DRUG ADMINISTRATION DURATION |
9 |
0.0003 |
| 937 |
FLATULENCE |
18 |
0.0003 |
| 938 |
DRUG INEFFECTIVE |
417 |
0.0003 |
| 939 |
GASTRIC CANCER |
8 |
0.0003 |
| 940 |
CHROMATURIA |
7 |
0.0003 |
| 941 |
SKIN ULCER |
8 |
0.0003 |
| 942 |
OSTEONECROSIS |
10 |
0.0003 |
| 943 |
HYPOACUSIS |
13 |
0.0003 |
| 944 |
CEREBROVASCULAR ACCIDENT |
50 |
0.0003 |
| 945 |
RHINORRHOEA |
19 |
0.0003 |
| 946 |
HEART RATE DECREASED |
10 |
0.0003 |
| 947 |
INJECTION SITE ERYTHEMA |
35 |
0.0003 |
| 948 |
NASAL CONGESTION |
16 |
0.0003 |
| 949 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
14 |
0.0003 |
| 950 |
LIMB DISCOMFORT |
8 |
0.0003 |
| 951 |
NERVOUS SYSTEM DISORDER |
8 |
0.0003 |
| 952 |
LACTIC ACIDOSIS |
8 |
0.0002 |
| 953 |
INFLUENZA |
27 |
0.0002 |
| 954 |
DRY EYE |
12 |
0.0002 |
| 955 |
FALL |
80 |
0.0002 |
| 956 |
FUNGAL INFECTION |
8 |
0.0002 |
| 957 |
NERVOUSNESS |
12 |
0.0002 |
| 958 |
HALLUCINATION |
17 |
0.0002 |
| 959 |
DIABETES MELLITUS |
17 |
0.0002 |
| 960 |
DYSKINESIA |
9 |
0.0002 |
| 961 |
MOOD SWINGS |
7 |
0.0002 |
| 962 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 963 |
OVERDOSE |
45 |
0.0002 |
| 964 |
BLOOD GLUCOSE INCREASED |
39 |
0.0002 |
| 965 |
HAEMORRHAGE |
21 |
0.0002 |
| 966 |
MYOCARDIAL INFARCTION |
35 |
0.0002 |
| 967 |
PRODUCT DOSE OMISSION |
13 |
0.0002 |
| 968 |
EYE PAIN |
11 |
0.0002 |
| 969 |
INTENTIONAL PRODUCT MISUSE |
17 |
0.0002 |
| 970 |
INJECTION SITE PAIN |
58 |
0.0002 |
| 971 |
COLORECTAL CANCER |
9 |
0.0002 |
| 972 |
EYE SWELLING |
7 |
0.0002 |
| 973 |
MENTAL DISORDER |
8 |
0.0002 |
| 974 |
IRRITABILITY |
11 |
0.0002 |
| 975 |
SURGERY |
10 |
0.0002 |
| 976 |
CATARACT |
10 |
0.0002 |
| 977 |
UNEVALUABLE EVENT |
12 |
0.0002 |
| 978 |
THERAPEUTIC RESPONSE UNEXPECTED |
7 |
0.0002 |
| 979 |
BALANCE DISORDER |
13 |
0.0002 |
| 980 |
TOXICITY TO VARIOUS AGENTS |
25 |
0.0001 |
| 981 |
THERAPY INTERRUPTED |
10 |
0.0001 |
| 982 |
SKIN BURNING SENSATION |
10 |
0.0001 |
| 983 |
CARDIAC FAILURE CONGESTIVE |
11 |
0.0001 |
| 984 |
ILLNESS |
14 |
0.0001 |
| 985 |
INJECTION SITE SWELLING |
10 |
0.0001 |
| 986 |
BREAST CANCER |
12 |
0.0001 |
| 987 |
CARDIAC DISORDER |
12 |
0.0001 |
| 988 |
DEVICE MALFUNCTION |
9 |
0.0001 |
| 989 |
SUICIDAL IDEATION |
11 |
0.0001 |
| 990 |
PRODUCT DOSE OMISSION ISSUE |
34 |
0.0001 |
| 991 |
ACNE |
7 |
0.0001 |
| 992 |
INCORRECT DOSE ADMINISTERED |
21 |
0.0001 |
| 993 |
DEVICE ISSUE |
8 |
0.0001 |
| 994 |
CHRONIC KIDNEY DISEASE |
6 |
0.0001 |
| 995 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
14 |
0.0001 |